Douglas G Altman

发表

Brackets (parentheses) in formulas

Douglas G Altman, J Martin Bland, D. Altman, 2011, BMJ : British Medical Journal.

Dichotomizing continuous predictors in multiple regression: a bad idea

Douglas G Altman, Willi Sauerbrei, Patrick Royston, 2006, Statistics in medicine.

The STROBE Extensions

Douglas G Altman, Darko Hren, Melissa K Sharp, 2018, Epidemiology.

Enhancing the usability of systematic reviews by improving the consideration and description of interventions

David Moher, Douglas G Altman, Philippe Ravaud, 2017, British Medical Journal.

Statistics Notes: Validating scales and indexes.

Douglas G Altman, J Martin Bland, D. G. Altman, 2002, BMJ.

Combining estimates of interest in prognostic modelling studies after multiple imputation: current practice and guidelines

Douglas G Altman, Patrick Royston, Andrea Marshall, 2009, BMC medical research methodology.

Comparison of techniques for handling missing covariate data within prognostic modelling studies: a simulation study

Douglas G Altman, Patrick Royston, Andrea Marshall, 2010, BMC medical research methodology.

Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration

Gary S Collins, Karel G M Moons, Douglas G Altman, 2015, Annals of Internal Medicine.

Uncertainty beyond sampling error

Douglas G Altman, J Martin Bland, D. Altman, 2014, BMJ : British Medical Journal.

Uncertainty and sampling error

Douglas G Altman, J Martin Bland, 2014, BMJ : British Medical Journal.

Some reflections on the evolution of meta-analysis.

Douglas G Altman, 2015, Research synthesis methods.

Design, analysis and reporting of multi-arm trials and strategies to address multiple testing.

Paul Monk, Matthias Briel, Douglas G Altman, 2020, International journal of epidemiology.

Guidelines for the design and statistical analysis of experiments using laboratory animals.

Douglas G Altman, Michael F W Festing, D. Altman, 2002, ILAR journal.

Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis (TRIPOD): The TRIPOD Statement.

Gary S Collins, Karel G M Moons, Douglas G Altman, 2015, European urology.

Missing covariate data in clinical research: when and when not to use the missing-indicator method for analysis

Karel G M Moons, James R Carpenter, A Rogier T Donders, 2012, Canadian Medical Association Journal.

Meta‐analysis combining parallel and cross‐over clinical trials. III: The issue of carry‐over

Douglas G Altman, Diana Elbourne, François Curtin, 2002, Statistics in medicine.

SPIRIT promotes protocol sharing.

David Moher, Douglas G Altman, An-Wen Chan, 2018, The lancet. Psychiatry.

Meta‐analysis combining parallel and cross‐over clinical trials. II: Binary outcomes

Douglas G Altman, Diana Elbourne, François Curtin, 2002, Statistics in medicine.

Statistical methodology for constructing gestational age‐related charts using cross‐sectional and longitudinal data: The INTERGROWTH‐21st project as a case study

Douglas G Altman, Eric O Ohuma, D. Altman, 2018, Statistics in medicine.

Sparse data bias: a problem hiding in plain sight

Sander Greenland, Douglas G Altman, Mohammad Ali Mansournia, 2016, British Medical Journal.

Sample size considerations for the external validation of a multivariable prognostic model: a resampling study

Gary S Collins, Douglas G Altman, Emmanuel O Ogundimu, 2015, Statistics in medicine.

The cost of dichotomising continuous variables

Patrick Royston, Douglas G Altman, P. Royston, 2006, BMJ : British Medical Journal.

The design of simulation studies in medical statistics

Patrick Royston, Douglas G Altman, Roger L Holder, 2006, Statistics in medicine.

u Acceptance Address: Good Reporting— An Essential Component of Good Science CSE Award for Meritorious Achievement

Douglas G Altman, D. Altman, 2007 .

Transparent reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): the TRIPOD statement.

Gary S Collins, Johannes B Reitsma, Karel G M Moons, 2015, Journal of clinical epidemiology.

STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies

David Moher, Johannes B Reitsma, Lotty Hooft, 2015, BMJ : British Medical Journal.

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies.

Douglas G Altman, Matthias Egger, Stuart J Pocock, 2014, International journal of surgery.

Prognosis research strategy (PROGRESS) 1: A framework for researching clinical outcomes

Richard D Riley, Karel G M Moons, Sara Schroter, 2013, BMJ : British Medical Journal.

SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials

David Moher, Douglas G Altman, Peter C Gøtzsche, 2013, BMJ.

Visualizing and assessing discrimination in the logistic regression model

Patrick Royston, Douglas G Altman, P. Royston, 2010, Statistics in medicine.

Prognosis research strategy (PROGRESS) 4: Stratified medicine research

Richard D Riley, Karel G M Moons, Sara Schroter, 2013, BMJ : British Medical Journal.

Reporting guidelines for oncology research: helping to maximise the impact of your research

Iveta Simera, Douglas G Altman, Shona Kirtley, 2018, British Journal of Cancer.

The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews

Douglas G Altman, Paula R Williamson, Susanna Dodd, 2010, BMJ : British Medical Journal.

An independent external validation and evaluation of QRISK cardiovascular risk prediction: a prospective open cohort study

Gary S Collins, Douglas G Altman, G. Collins, 2009, BMJ : British Medical Journal.

Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses

Douglas G Altman, Jonathan J Deeks, Fujian Song, 2003, BMJ : British Medical Journal.

Better reporting of randomised controlled trials: the CONSORT statement

Douglas G Altman, D. Altman, 1996, BMJ.

The CONSORT statement: Revised recommendations for improving the quality of reports of parallel-group randomized trials (Reprinted from JAMA 2001;285:1987-1991)

David Moher, Douglas G Altman, Kenneth F Schulz, 2001 .

Reporting clinical research: guidance to encourage accurate and transparent research reporting.

Iveta Simera, Douglas G Altman, Shona Kirtley, 2012, Maturitas.

Reporting of participant flow diagrams in published reports of randomized trials

Gary S Collins, Sally Hopewell, Douglas G Altman, 2011, Trials.

The effects of excluding patients from the analysis in randomised controlled trials: meta-epidemiological study

Douglas G Altman, Peter Jüni, Eveline Nüesch, 2009, BMJ : British Medical Journal.

Animal Research: Reporting in vivo Experiments—The ARRIVE Guidelines

Douglas G Altman, Innes C Cuthill, Michael Emerson, 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Predicting the adverse risk of statin treatment: an independent and external validation of Qstatin risk scores in the UK

Gary S Collins, Douglas G Altman, G. Collins, 2012, Heart.

Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD Statement

Gary S Collins, Johannes B Reitsma, Douglas G Altman, 2015, BMC Medicine.

Evaluation of the Cochrane Collaboration’s tool for assessing the risk of bias in randomized trials: focus groups, online survey, proposed recommendations and their implementation

David Moher, Jonathan AC Sterne, Douglas G Altman, 2014, Systematic Reviews.

EQUATOR: reporting guidelines for health research.

Iveta Simera, David Moher, John Hoey, 2008, Lancet.

The CARE Guidelines: Consensus‐Based Clinical Case Reporting Guideline Development

David Moher, Douglas G Altman, David Riley, 2013, Headache.

IDEAL framework for surgical innovation 2: observational studies in the exploration and assessment stages

Douglas G Altman, Jonathan A Cook, Peter McCulloch, 2013, BMJ.

REporting recommendations for tumour MARKer prognostic studies (REMARK).

Douglas G Altman, Willi Sauerbrei, Massimo Gion, 2005, European journal of cancer.

Potential impact on estimated treatment effects of information lost to follow-up in randomised controlled trials (LOST-IT): systematic review

Gordon H Guyatt, Matthias Briel, Jason W Busse, 2012, BMJ : British Medical Journal.

A history of the evolution of guidelines for reporting medical research: the long road to the EQUATOR Network

Iveta Simera, Douglas G Altman, D. Altman, 2016, Journal of the Royal Society of Medicine.

Subgroup Analysis of Trials Is Rarely Easy (SATIRE): a study protocol for a systematic review to characterize the analysis, reporting, and claim of subgroup effects in randomized trials

Gordon H Guyatt, Matthias Briel, Jason W Busse, 2009, Trials.

Reporting performance of prognostic models in cancer: a review

Patrick Royston, Susan Mallett, Douglas G Altman, 2010, BMC medicine.

CONSORT Statement for Randomized Trials of Nonpharmacologic Treatments: A 2017 Update and a CONSORT Extension for Nonpharmacologic Trial Abstracts.

David Moher, Douglas G Altman, Isabelle Boutron, 2017, Annals of internal medicine.

Standard deviations and standard errors

Douglas G Altman, J Martin Bland, D. Altman, 2005, BMJ : British Medical Journal.

Ghost Authorship in Industry-Initiated Randomised Trials

Douglas G Altman, Peter C Gøtzsche, Asbjørn Hróbjartsson, 2007, PLoS medicine.

Statistical methods for assessing the influence of study characteristics on treatment effects in ‘meta‐epidemiological’ research

Douglas G Altman, Peter Jüni, Jonathan A C Sterne, 2002, Statistics in medicine.

Quantification of the completeness of follow-up

Douglas G Altman, D. Altman, T. Clark, 2002, The Lancet.

Interaction revisited: the difference between two estimates

Douglas G Altman, D. Altman, J. Bland, 2003, BMJ : British Medical Journal.

The logrank test

Douglas G Altman, J Martin Bland, D. Altman, 2004, BMJ : British Medical Journal.

The relation between treatment benefit and underlying risk in meta-analysis

Douglas G Altman, D. Altman, S. Thompson, 1996, BMJ.

Impact of peer review on reports of randomised trials published in open peer review journals: retrospective before and after study

Gary S Collins, Sally Hopewell, Douglas G Altman, 2014, BMJ : British Medical Journal.

Missing outcomes in randomized trials: addressing the dilemma

Douglas G Altman, D. Altman, 2009, Open medicine : a peer-reviewed, independent, open-access journal.

Meta‐analysis combining parallel and cross‐over clinical trials. I: Continuous outcomes

Douglas G Altman, Diana Elbourne, François Curtin, 2002, Statistics in medicine.

An independent and external validation of QRISK2 cardiovascular disease risk score: a prospective open cohort study

Gary S Collins, Douglas G Altman, G. Collins, 2010, BMJ : British Medical Journal.

How can medical journals help prevent poor medical research? Some opportunities presented by electronic publishing

Douglas G Altman, D. Altman, I. Chalmers, 1999, The Lancet.

Discrepancies in sample size calculations and data analyses reported in randomised trials: comparison of publications with protocols

Douglas G Altman, Peter C Gøtzsche, Asbjørn Hróbjartsson, 2008, BMJ : British Medical Journal.

[The CONSORT statenent: Revised Recommendations For Improving the Quality of Reports of Parallel-Group Randomized Trials].

David Moher, Douglas G Altman, Kenneth F Schulz, 2005, Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine.

Impact of an online writing aid tool for writing a randomized trial report: the COBWEB (Consort-based WEB tool) randomized controlled trial

Douglas G Altman, Isabelle Boutron, Philippe Ravaud, 2015, BMC Medicine.

PRISMA harms checklist: improving harms reporting in systematic reviews

David Moher, Douglas G Altman, Su Golder, 2016, British Medical Journal.

Forest plots in reports of systematic reviews: a cross-sectional study reviewing current practice.

David Moher, Douglas G Altman, David L Schriger, 2010, International journal of epidemiology.

Assessing risk of bias in randomised clinical trials included in Cochrane Reviews: the why is easy, the how is a challenge.

David Moher, Douglas G Altman, Isabelle Boutron, 2013, The Cochrane database of systematic reviews.

STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration

Johannes B Reitsma, Lotty Hooft, Patrick M M Bossuyt, 2016, BMJ Open.

The CARE Guidelines: Consensus-based Clinical Case Reporting Guideline Development

David Moher, Douglas G Altman, David Riley, 2013, Journal of Medical Case Reports.

Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research.

Douglas G Altman, William J Browne, Michael Emerson, 2012, Veterinary clinical pathology.

Does use of the CONSORT Statement impact the completeness of reporting of randomised controlled trials published in medical journals? A Cochrane reviewa

David Moher, Douglas G Altman, Larissa Shamseer, 2012, Systematic Reviews.

Analysis and reporting of factorial trials: a systematic review.

Douglas G Altman, Sharon E Straus, David L Sackett, 2003, JAMA.

Reporting methods in studies developing prognostic models in cancer: a review

Patrick Royston, Susan Mallett, Douglas G Altman, 2010, BMC medicine.

Systematic reviews of diagnostic tests in cancer: review of methods and reporting

Steve Halligan, Sally Hopewell, Victoria Cornelius, 2006, BMJ : British Medical Journal.

Peer review of statistics in medical research. Reporting power calculations is important.

David Moher, Douglas G Altman, Kenneth F Schulz, 2002, BMJ.

Association between trial registration and positive study findings: cross sectional study (Epidemiological Study of Randomized Trials—ESORT)

Sally Hopewell, Douglas G Altman, Ayodele Odutayo, 2017, British Medical Journal.

CONSORT extension for reporting N-of-1 trials (CENT) 2015: explanation and elaboration.

David Moher, Douglas G Altman, Robyn Tate, 2015, Journal of clinical epidemiology.

Predicting the 10 year risk of cardiovascular disease in the United Kingdom: independent and external validation of an updated version of QRISK2

Gary S Collins, Douglas G Altman, G. Collins, 2012, BMJ : British Medical Journal.

IDEAL framework for surgical innovation 1: the idea and development stages

Douglas G Altman, Carl Heneghan, Jonathan A Cook, 2013, BMJ.

Comparison of protocols and registry entries to published reports for randomised controlled trials.

Douglas G Altman, Paula R Williamson, Kerry Dwan, 2011, The Cochrane database of systematic reviews.

CARE guidelines for case reports: explanation and elaboration document.

David Moher, Douglas G Altman, Larissa Shamseer, 2017, Journal of clinical epidemiology.

EQUATOR: reporting guidelines for health research

Iveta Simera, David Moher, John Hoey, 2008, Open medicine : a peer-reviewed, independent, open-access journal.

Endorsement of the CONSORT statement by high impact medical journals: survey of instructions for authors

Douglas G Altman, D. Altman, 2005, BMJ : British Medical Journal.

Revision of the ARRIVE guidelines: rationale and scope

Ulrich Dirnagl, Douglas G Altman, Sabina Alam, 2018, BMJ Open Science.

Methods and processes of the CONSORT Group: example of an extension for trials assessing nonpharmacologic treatments.

David Moher, Douglas G Altman, Isabelle Boutron, 2008, Annals of internal medicine.

Evolution of poor reporting and inadequate methods over time in 20 920 randomised controlled trials included in Cochrane reviews: research on research study

David Moher, Douglas G Altman, Isabelle Boutron, 2017, British Medical Journal.

Ensuring trial validity by data quality assurance and diversification of monitoring methods

Douglas G Altman, Marc Buyse, Frank E Harrell, 2008, Clinical trials.

Statistics Notes: Bootstrap resampling methods

Douglas G Altman, J Martin Bland, D. Altman, 2015, BMJ : British Medical Journal.

CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials.

David Moher, Douglas G Altman, Kenneth F Schulz, 2010, Obstetrics and gynecology.

Prognosis and prognostic research: validating a prognostic model

Yvonne Vergouwe, Patrick Royston, Douglas G Altman, 2009, BMJ : British Medical Journal.

Comparison of imputation methods for handling missing covariate data when fitting a Cox proportional hazards model: a resampling study

Douglas G Altman, Roger L Holder, D. Altman, 2010, BMC medical research methodology.

Tracking eye gaze during interpretation of endoluminal three-dimensional CT colonography: visual perception of experienced and inexperienced readers.

Emma Helbren, Steve Halligan, Susan Mallett, 2014, Radiology.

CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomised trials.

David Moher, Douglas G Altman, Kenneth F Schulz, 2010, Journal of clinical epidemiology.

Credibility of claims of subgroup effects in randomised controlled trials: systematic review

Gordon H Guyatt, Matthias Briel, Jason W Busse, 2012, BMJ : British Medical Journal.

Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study

Douglas G Altman, Richard M Martin, Peter Jüni, 2008, BMJ : British Medical Journal.

A new classification of spin in systematic reviews and meta-analyses was developed and ranked according to the severity.

David Moher, Douglas G Altman, Isabelle Boutron, 2016, Journal of clinical epidemiology.

Epidemiology and Reporting Characteristics of Systematic Reviews

David Moher, Douglas G Altman, Andrea C Tricco, 2007, PLoS medicine.

Meta-analyses involving cross-over trials: methodological issues.

Douglas G Altman, Julian P T Higgins, Andy Vail, 2002, International journal of epidemiology.

Parametric v non-parametric methods for data analysis

Douglas G Altman, J Martin Bland, D. Altman, 2009, BMJ : British Medical Journal.

Key Issues in Conducting a Meta-Analysis of Gene Expression Microarray Datasets

Douglas G Altman, Adrian Mondry, Adaikalavan Ramasamy, 2008, PLoS medicine.

Primer: an evidence-based approach to prognostic markers

Richard D Riley, Douglas G Altman, D. Altman, 2005, Nature Clinical Practice Oncology.

How to obtain the confidence interval from a P value

Douglas G Altman, J Martin Bland, D. Altman, 2011, BMJ : British Medical Journal.

Reporting and interpretation of randomized controlled trials with statistically nonsignificant results for primary outcomes.

Douglas G Altman, Isabelle Boutron, Philippe Ravaud, 2010, JAMA.

Statistics Notes: Units of analysis

Douglas G Altman, D. Altman, Martin Bland J, 1997, BMJ.

Describing reporting guidelines for health research: a systematic review.

Iveta Simera, David Moher, John Hoey, 2011, Journal of clinical epidemiology.

Risk stratification for in-hospital mortality in acutely decompensated heart failure.

Patrick Royston, Douglas G Altman, P. Royston, 2005, JAMA.

Bayesian random effects meta‐analysis of trials with binary outcomes: methods for the absolute risk difference and relative risk scales by D. E. Warn, S. G. Thompson and D. J. Spiegelhalter, Statistics in Medicine 2002; 21: 1601–1623

Douglas G Altman, D. Altman, K. O'rourke, 2005, Statistics in medicine.

Comparison of registered and published primary outcomes in randomized controlled trials.

David Moher, Douglas G Altman, Isabelle Boutron, 2009, JAMA.

Design, analysis, and presentation of crossover trials

Gordon H Guyatt, Douglas G Altman, Edward J Mills, 2009, Trials.

Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement.

Douglas G Altman, Gilda Piaggio, Stuart J Pocock, 2006, JAMA.

How to obtain the P value from a confidence interval

Douglas G Altman, J Martin Bland, D. Altman, 2011, BMJ : British Medical Journal.

Inverse probability weighting

Douglas G Altman, Mohammad Ali Mansournia, D. Altman, 2016, British Medical Journal.

Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals.

David Moher, Sofia Dias, Douglas G Altman, 2012, The Cochrane database of systematic reviews.

[The Strengthening the Reporting of Observational Studies in Epidemiology [STROBE] statement: guidelines for reporting observational studies].

Douglas G Altman, Peter C Gøtzsche, Matthias Egger, 2007, Gaceta sanitaria.

Epidemiology and Reporting Characteristics of Systematic Reviews of Biomedical Research: A Cross-Sectional Study

David Moher, Lun Li, Douglas G Altman, 2016, PLoS medicine.

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies.

Douglas G Altman, Peter C Gøtzsche, Matthias Egger, 2014, International journal of surgery.

The evolution of assessing bias in Cochrane systematic reviews of interventions: celebrating methodological contributions of the Cochrane Collaboration

David Moher, Douglas G Altman, Isabelle Boutron, 2013, Systematic Reviews.

[CONSORT for reporting randomized controlled trials in journal and conference abstracts: explanation and elaboration].

David Moher, Elizabeth Wager, Douglas G Altman, 2008, Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine.

Flaws in the application and interpretation of statistical analyses in systematic reviews of therapeutic interventions were common: a cross-sectional analysis.

David Moher, Douglas G Altman, Andrea C Tricco, 2018, Journal of clinical epidemiology.

Basic statistical reporting for articles published in biomedical journals: the "Statistical Analyses and Methods in the Published Literature" or the SAMPL Guidelines.

Douglas G Altman, T. A. Lang, Thomas A Lang, 2015, International journal of nursing studies.

Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension.

David Moher, Douglas G Altman, Melanie Calvert, 2013, JAMA.

From submission to publication: a retrospective review of the tables and figures in a cohort of randomized controlled trials submitted to the British Medical Journal.

Sara Schroter, Douglas G Altman, David L Schriger, 2006, Annals of emergency medicine.

Prognosis research: toward evidence-based results and a Cochrane methods group.

Richard D Riley, Jill Hayden, Douglas G Altman, 2007, Journal of clinical epidemiology.

Scientific hypotheses can be tested by comparing the effects of one treatment over many diseases in a systematic review.

Karla Hemming, P. J. Chilton, Douglas G Altman, 2014, Journal of clinical epidemiology.

Relation of completeness of reporting of health research to journals’ endorsement of reporting guidelines: systematic review

David Moher, John Hoey, Douglas G Altman, 2014, BMJ : British Medical Journal.

Quantifying the impact of different approaches for handling continuous predictors on the performance of a prognostic model

Gary S Collins, Douglas G Altman, Jonathan A Cook, 2016, Statistics in medicine.

Ten steps towards improving prognosis research

Richard D Riley, Douglas G Altman, Harry Hemingway, 2009, BMJ : British Medical Journal.

The Adaptive designs CONSORT Extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design

Michael A Proschan, Philip Pallmann, Adrian P Mander, 2020, BMJ.

Prognosis and prognostic research: Developing a prognostic model

Yvonne Vergouwe, Patrick Royston, Douglas G Altman, 2009, BMJ : British Medical Journal.

The time has come to register diagnostic and prognostic research.

Douglas G Altman, D. Altman, 2014, Clinical chemistry.

The National Institutes of Health and guidance for reporting preclinical research

David Moher, Douglas G Altman, Gerd Antes, 2015, BMC Medicine.

A pragmatic–explanatory continuum indicator summary (PRECIS): a tool to help trial designers

Ian Harvey, Douglas G Altman, Andrew D Oxman, 2009, Canadian Medical Association Journal.

CONSORT extension for reporting N-of-1 trials (CENT) 2015 Statement.

David Moher, Douglas G Altman, Robyn Tate, 2016, Journal of clinical epidemiology.

Reducing waste from incomplete or unusable reports of biomedical research

David Moher, Elizabeth Wager, Douglas G Altman, 2014, The Lancet.

The quality of reports of randomised trials in 2000 and 2006: comparative study of articles indexed in PubMed

Sally Hopewell, Douglas G Altman, Ly-Mee Yu, 2010, BMJ : British Medical Journal.

Incorporation of assessments of risk of bias of primary studies in systematic reviews of randomised trials: a cross-sectional study

Sally Hopewell, Douglas G Altman, Isabelle Boutron, 2013, BMJ Open.

Helping editors, peer reviewers and authors improve the clarity, completeness and transparency of reporting health research

Iveta Simera, David Moher, John Hoey, 2008, BMC medicine.

Reporting recommendations for tumor marker prognostic studies.

Douglas G Altman, Willi Sauerbrei, Massimo Gion, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Blinding in clinical trials and other studies

Douglas G Altman, D. Altman, S. Day, 2000, BMJ : British Medical Journal.

Methodological problems in the use of indirect comparisons for evaluating healthcare interventions: survey of published systematic reviews

Douglas G Altman, Fujian Song, Yoon K Loke, 2009, BMJ : British Medical Journal.

Correlation in restricted ranges of data

Douglas G Altman, J Martin Bland, D. Altman, 2011, BMJ : British Medical Journal.

Impact of spin in the abstracts of articles reporting results of randomized controlled trials in the field of cancer: the SPIIN randomized controlled trial.

Sally Hopewell, Douglas G Altman, Isabelle Boutron, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomised Trials

David Moher, Douglas G Altman, Kenneth F Schulz, 2010, PLoS medicine.

Predicting risk of osteoporotic and hip fracture in the United Kingdom: prospective independent and external validation of QFractureScores

Gary S Collins, Susan Mallett, Douglas G Altman, 2011, BMJ : British Medical Journal.

Deficiencies in the publication and reporting of the results of systematic reviews presented at scientific medical conferences.

Sally Hopewell, Douglas G Altman, Isabelle Boutron, 2015, Journal of clinical epidemiology.

Treatment allocation by minimisation

Douglas G Altman, J Martin Bland, D. Altman, 2005, BMJ : British Medical Journal.

Animal Research: Reporting In Vivo Experiments: The ARRIVE Guidelines

Douglas G Altman, Innes C Cuthill, Michael Emerson, 2010, British journal of pharmacology.

Comparisons against baseline within randomised groups are often used and can be highly misleading

Douglas G Altman, J Martin Bland, D. Altman, 2011, Trials.

Use of the Internet by print medical journals in 2003 to 2009: a longitudinal observational study.

Douglas G Altman, David L Schriger, D. Altman, 2011, Annals of emergency medicine.

Can we be certain that storage duration of transfused red blood cells does not affect patient outcomes?

Douglas G Altman, D. Altman, M. Trivella, 2019, BMJ.

Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): Extending the CONSORT Statement

David Moher, Douglas G Altman, Hugh MacPherson, 2010, PLoS medicine.

Agreed statistics: measurement method comparison.

Douglas G Altman, J Martin Bland, D. Altman, 2012, Anesthesiology.

Epidemiology and reporting of randomised trials published in PubMed journals

Douglas G Altman, An-Wen Chan, D. Altman, 2005, The Lancet.

Prognostic Models: A Methodological Framework and Review of Models for Breast Cancer

Douglas G Altman, D. Altman, 2009, Cancer investigation.

Systematic reviews of evaluations of prognostic variables

Douglas G Altman, D. Altman, Douglas G. Altman, 2001, BMJ : British Medical Journal.

Method for tracking eye gaze during interpretation of endoluminal 3D CT colonography: technical description and proposed metrics for analysis.

Steve Halligan, Susan Mallett, Darren Boone, 2013, Radiology.

Core Outcome Set-STAndards for Development: The COS-STAD recommendations

Jane M Blazeby, Douglas G Altman, Paula R Williamson, 2017, PLoS medicine.

Treatment allocation in controlled trials: why randomise?

Douglas G Altman, J Martin Bland, D. Altman, 1999, BMJ.

Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis

Sally Hopewell, Douglas G Altman, Ayodele Odutayo, 2016, British Medical Journal.

ORAL PRESENTATIONS

Jane M Blazeby, David Moher, Douglas G Altman, 1993, European Surgical Research.

CONSORT 2010 changes and testing blindness in RCTs

David Moher, Douglas G Altman, Kenneth F Schulz, 2010, The Lancet.

Randomisation in the SYMPHONY trial

Douglas G Altman, D. Altman, 2000, The Lancet.

A guide to systematic review and meta-analysis of prognostic factor studies

Richard D Riley, Kym I E Snell, Gary S Collins, 2019, British Medical Journal.

Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study

Douglas G Altman, Peter Jüni, Matthias Egger, 2010, BMJ : British Medical Journal.

Data sharing among data monitoring committees and responsibilities to patients and science

Douglas G Altman, Nancy Owens, Iain Chalmers, 2013, Trials.

Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): Extending the CONSORT statement.

David Moher, Douglas G Altman, Hugh MacPherson, 2010, Journal of evidence-based medicine.

The Good Clinical Practice guideline: a bronze standard for clinical research

David Moher, Douglas G Altman, Kenneth F Schulz, 2005, The Lancet.

Analysis of continuous data from small samples

Douglas G Altman, J Martin Bland, D. Altman, 2009, BMJ : British Medical Journal.

Developing a prognostic model in the presence of missing data: an ovarian cancer case study.

Douglas G Altman, D. Altman, T. Clark, 2003, Journal of clinical epidemiology.

Specifying the target difference in the primary outcome for a randomised controlled trial: guidance for researchers

Douglas G Altman, Andrew H Briggs, Craig R Ramsay, 2015, Trials.

How to randomise

Douglas G Altman, J Martin Bland, D. Altman, 1999, BMJ.

Survival plots of time-to-event outcomes in clinical trials: good practice and pitfalls

Douglas G Altman, Stuart J Pocock, S. Pocock, 2002, The Lancet.

Incremental benefit of computer-aided detection when used as a second and concurrent reader of CT colonographic data: multiobserver study.

Steve Halligan, Susan Mallett, Douglas G Altman, 2011, Radiology.

Risk and treatment effect heterogeneity: re-analysis of individual participant data from 32 large clinical trials.

Issa J Dahabreh, Douglas G Altman, David M Kent, 2016, International journal of epidemiology.

Odds ratios should be avoided when events are common

Douglas G Altman, D. Altman, D. Sackett, 1998, BMJ.

Taking healthcare interventions from trial to practice

Sophie Hill, Douglas G Altman, Isabelle Boutron, 2010, BMJ : British Medical Journal.

Meta-analysis, Simpson's paradox, and the number needed to treat

Douglas G Altman, Jonathan J Deeks, D. Altman, 2002, BMC medical research methodology.

Improving the reporting of randomised trials: the CONSORT Statement and beyond

David Moher, Douglas G Altman, Kenneth F Schulz, 2012, Statistics in medicine.

Prognosis and prognostic research: what, why, and how?

Yvonne Vergouwe, Patrick Royston, Douglas G Altman, 2009, BMJ : British Medical Journal.

Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration

Douglas G Altman, Willi Sauerbrei, Lisa M McShane, 2012, BMC Medicine.

Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.

Douglas G Altman, Peter C Gøtzsche, Matthias Egger, 2008, BMJ.

The content of medical journal Instructions for authors.

Douglas G Altman, Sanjay Arora, David L Schriger, 2006, Annals of emergency medicine.

Association between randomised trial evidence and global burden of disease: cross sectional study (Epidemiological Study of Randomized Trials—ESORT)

Sally Hopewell, Douglas G Altman, Kazem Rahimi, 2015, BMJ : British Medical Journal.

Development and validation of a prediction model with missing predictor data: a practical approach.

Yvonne Vergouwe, Patrick Royston, Douglas G Altman, 2010, Journal of clinical epidemiology.

Systematic reviews in health care: Assessing the quality of controlled clinical trials.

Douglas G Altman, Peter Jüni, D. Altman, 2001, BMJ.

A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers.

Ian Harvey, Douglas G Altman, Andrew D Oxman, 2009, Journal of clinical epidemiology.

Interpreting diagnostic accuracy studies for patient care

Gary S Collins, Steve Halligan, Susan Mallett, 2012, BMJ : British Medical Journal.

SPIRIT 2013 Statement: defining standard protocol items for clinical trials.

David Moher, Douglas G Altman, Peter C Gøtzsche, 2015, Revista panamericana de salud publica = Pan American journal of public health.

Developing core outcome sets for clinical trials: issues to consider

Jane M Blazeby, Douglas G Altman, Elizabeth Gargon, 2012, Trials.

Effect of arterial revascularisation on survival: a systematic review of studies comparing bilateral and single internal mammary arteries

Douglas G Altman, Roberto D'Amico, D. Altman, 2001, The Lancet.